ALXA Key Stats
| Income Statement | |
| Revenue TTM | 4.07M |
| Revenue Quarterly YoY Growth | -61.31% |
| EPS Diluted TTM | -2.154 |
| EPS Diluted Quarterly YoY Growth | |
| Net Income TTM | -27.98M |
| Profitability | |
| Gross Profit Margin Quarterly | |
| Profit Margin Quarterly | -1409% |
| Dividend | |
| Dividend Yield | 0.00% |
| Payout Ratio TTM Pro | Go Pro |
| Current Valuation | |
| Market Cap | 70.21M |
| Enterprise Value | 52.49M |
| PE Ratio TTM | |
| PE 10 Pro | Go Pro |
| PEG Ratio | |
| Price / Book Value | 27.29 |
| Other | |
| Beta Pro | Go Pro |
| Debt to Equity Ratio | 0.00 |
| Free Cash Flow | -7.493M |
| Return on Equity | -914.8% |
ALXA News
- Nasdaq stocks posting largest percentage increases May 20
- Alexza Pharmaceuticals Has A Partner In Big Pharma, Now What? May 15
- Alexza Pharmaceuticals: A Teva Partnership Of Immense Meaning May 15
- Alexza Pharmaceuticals Management Discusses Q1 2013 Results - Earnings Call Tran... May 14
- Alexza Pharmaceuticals, Inc. Earnings Call scheduled for 5:00 pm ET today May 14
- Alexza Pharmaceuticals, Inc. (ALXA) Posts Q1 Loss of $1.31/Share Street Insider May 14
- Alexza Reports 2013 First Quarter Financial Results PR Newswire May 14
- ALEXZA PHARMACEUTICALS INC. Files SEC form 8-K, Results of Operations and Financ... May 14
- Teva - Alexza Sign Deal for Adasuve May 13
- Alexza Pharmaceuticals Earnings Preview: Get Ahead of the Analysts May 13
ALXA Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Alexza Pharmaceuticals is up 16.80% over the last year vs S&P 500 Total Return up 31.59%, Teva Pharmaceutical Industries up 5.82%, and Forest Laboratories up 14.40%.
ALXA Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these ALXA related companies
Pro Ratings for ALXA
Pro Report PDF for ALXA
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.
Download ALXA Pro Report PDF
Pro Strategies Featuring ALXA
Did Alexza Pharmaceuticals make it into our Pro Portfolio Strategies?
ALXA Profile
Exchange: NASDAQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Other ALXA Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| ALXA | 4.45 | +0.06 | +1.37% | 70.21M |
